MétaCan
Menu
Back to cohort
Record W4280593482 · doi:10.51731/cjht.2022.330

An Overview of New and Emerging Technologies for Early Diagnosis of Alzheimer Disease

2022· article· en· W4280593482 on OpenAlexaboutno aff
Charlotte Wells, Jennifer Horton

Bibliographic record

VenueCanadian Journal of Health Technologies · 2022
Typearticle
Languageen
FieldMedicine
TopicCholinesterase and Neurodegenerative Diseases
Canadian institutionsnot available
Fundersnot available
KeywordsDiseaseBiomarkerMedicineCognitive declineAmyloid betaAmyloid (mycology)Alzheimer's diseaseBioinformaticsNeurosciencePathologyDementiaPsychologyBiology

Abstract

fetched live from OpenAlex

Alzheimer disease is a progressive neurologic condition that leads to the decline of cognitive functioning and eventual death. There is currently no cure. Proposed causes of Alzheimer disease include the amyloid hypothesis, which suggests that it is caused by a buildup of amyloid-beta and tau proteins in the brain, leading to cell death. Recent diagnostic tools focus on amyloid and tau proteins as potential markers of the disease, and new treatments are also focusing on amyloid and tau formation. Earlier diagnosis of Alzheimer disease allows time for planning for care and support needs before symptoms worsen. It also allows for both drug and non-drug treatments to be used earlier, which may prolong time with a higher quality of life. Emerging diagnostic tools include biomarker-based tools, such as MRI, PET, CT, blood-based biomarkers, cerebrospinal fluid-based biomarkers, ocular testing, and salivary biomarkers. The majority of these tools are in the research phase, although imaging is often used in combination with cognitive testing to diagnose Alzheimer disease. One blood-based biomarker test is available in the US (paid out of pocket). It is unclear whether testing will be available in Canada or when this will happen.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.004
metaresearch head score (Gemma)0.004
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.016
Threshold uncertainty score0.032

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0040.004
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0070.004
Science and technology studies0.0010.001
Scholarly communication0.0030.003
Open science0.0020.001
Research integrity0.0030.003
Insufficient payload (model declined to judge)0.0090.005

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.119
GPT teacher head0.380
Teacher spread0.261 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations6
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueCanadian Journal of Health TechnologiesSame topicCholinesterase and Neurodegenerative DiseasesFrench-language works237,207